OOIR: Observatory of International Research

Papers

(The TQCC of Seminars in Radiation Oncology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Spatially Fractionated Radiotherapy in the Era of Immunotherapy	52
Global Workforce and Access: Demand, Education, Quality	50
The seemingly contradictory roles of radiation as focal to systemic therapy in hematologic malignancies	37
The Quality Assurance of a 1.5 T MR-Linac	28
Extremity and Truncal Soft Tissue Sarcoma: Risk Assessment and Multidisciplinary Management	27
Pushing the Envelope: The Role of Radiation Therapy in Non-muscle-Invasive Bladder Cancer	25
Artificial Intelligence for Radiation Oncology Applications Using Public Datasets	24
Rectal Cancer MRI Guided Radiotherapy: A Practical Review for the Physician	24
Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology	24
The Role of Radiation Therapy for Palliation of Hematologic Malignancies	23
[18F]FDG-PET-Based Personalized Radiotherapy Dose Prescription	20
Integrating the Patient's Voice in Toxicity Reporting and Treatment Decisions for Breast Radiotherapy	20
How Small Can We Go? Partial Bladder Radiation Therapy and Brachytherapy	20
Artificial Intelligence for Outcome Modeling in Radiotherapy	20
Introduction: Personalization of Cancer Care for Older Adults	18
Are We Ready for Life in the Fast Lane? A Critical Review of Preoperative Hypofractionated Radiotherapy for Localized Soft Tissue Sarcoma	18
Treatment De-intensification for HPV-associated Oropharyngeal Cancer: A Definitive Surgery Paradigm	15
The Role of Radiotherapy in Lymphoma Patients Undergoing CAR T Therapy: Past, Present, and Future	15
Histology Specific Molecular Biomarkers: Ushering in a New Era of Precision Radiation Oncology	15
Radiation Therapy for Painful Bone Metastases: Fractionation, Recalcification, and Symptom Control	15
Uncertainty Assessment for Deep Learning Radiotherapy Applications	13
Radiotherapy Combined with Intralesional Immunostimulatory Agents for Soft Tissue Sarcomas	13
Normal Tissue Toxicity Prediction: Clinical Translation on the Horizon	13
Myths About Bladder Preservation in Muscle-Invasive Bladder Cancer	12
Intrafraction Motion Management With MR-Guided Radiation Therapy	12

Novel Survivorship Paradigms in Head/Neck Cancer	12
Targeting Noncanonical Regulators of the DNA Damage Response to Selectively Overcome Cancer Radiation Resistance	11
Reirradiation for Locally Recurrent Head and Neck Cancer: State-of-the-Art and Future Directions	11
Optimizing Informed Consent in Cancer Clinical Trials	11
De-escalation of Adjuvant Therapy in Operatively Managed HPV Associated Oropharyngeal Carcinoma: Current Status and Future Directions	11
The Many Faces of Muscle-Invasive Bladder Cancer: Histopathological and Molecular Characterization	11
Technical Giants But Biologic Infants: Defining a More Sophisticated Role for Local Therapy in Metastatic Disease	10
Advances in Automated Treatment Planning	10
Biology of HPV Mediated Carcinogenesis and Tumor Progression	10
The Role of Radiotherapy in Hematologic Malignancies in Children, Adolescents, and Young Adults	9
Safe Hypofractionation Amid Diverse Technologies: Using Teamwork to Manage the Complexity	9
Innovations in Physics, Biology and Clinical Translation of Spatially Fractionated and FLASH Radiotherapy	9
Immunotherapy With Curative Intent Radiotherapy for Patients With Cancers of the Head and Neck	9
Mature Experiences Using Local Therapy for Oligometastases	9
Green Horizons in Oncology: A Blueprint for Environmentally Sustainable Radiation Therapy Facilities	8
Bladder Preservation for Muscle-Invasive Bladder Cancer With Variant Histology	8
Optimizing GRID and Lattice Spatially Fractionated Radiation Therapy: Innovative Strategies for Radioresistant and Bulky Tumor Management	8
Advances and Challenges in Conducting Clinical Trials With Proton Beam Therapy	8
Early-stage Breast Cancer: Tailored External Beam Fractionation Approaches for Treatment of the Whole or Partial Breast	8
Radiation Sensitivity: The Rise of Predictive Patient-Derived Cancer Models	7
Hypofractionated Radiation Therapy in the Definitive Management of Head and Neck Cancer	7
MRI-Guided Radiation Therapy—An Emerging and Disruptive Process of Care: Healthcare Economic and Policy Considerations	7
Future Directions in the Use of SAbR for the Treatment of Oligometastatic Cancers	7
Brain Metastases: Is There Still a Role for Whole-Brain Radiation Therapy?	7
Hypofractionation in Older Adults With Glioblastoma	6
Democratizing FLASH Radiotherapy	6
Opportunity in Complexity: Harnessing Molecular Biomarkers and Liquid Biopsies for Personalized Sarcoma Care	6
Theranostics and Patient-Specific Dosimetry	6
The Use of MR-Guided Radiation Therapy for Head and Neck Cancer and Recommended Reporting Guidance	6
Introduction: Radiation Therapy in Oligometastatic Disease	6
The History and Future of Multidisciplinary Cancer Care	6
Advancing Towards Personalized Prescription of Radiotherapy Dose	6